A Study to Assess the Safety of TPM502 in Adults With Celiac Disease

NCT05660109 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: TPM502
OTHER: Placebo

Sponsor

Topas Therapeutics GmbH